These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38725626)

  • 1. Research progress in endometriosis-associated ovarian cancer.
    Tang L; Bian C
    Front Oncol; 2024; 14():1381244. PubMed ID: 38725626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare but Still There: A Scoping Review on Endometriosis-Associated Ovarian Cancer.
    Livori K; Calleja-Agius J
    Discov Med; 2024 Mar; 36(182):467-481. PubMed ID: 38531788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.
    Erzen M; Rakar S; Klancnik B; Syrjänen K
    Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics.
    Li Q; Sun Y; Zhang X; Wang L; Wu W; Wu M; Meng C; Liu G
    Cancer Biol Ther; 2019; 20(7):1029-1034. PubMed ID: 30913953
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification and Validation of Prognostic Markers for Endometriosis-Associated Ovarian Cancer.
    Yang H; Deng Y; Dong Y; Ma Y; Yang L
    Int J Med Sci; 2024; 21(10):1903-1914. PubMed ID: 39113897
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
    Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
    J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Links between Endometriosis and Endometriosis-Associated Ovarian Cancer-A Narrative Review (Endometriosis-Associated Cancer).
    Pejovic T; Cathcart AM; Alwaqfi R; Brooks MN; Kelsall R; Nezhat FR
    Life (Basel); 2024 May; 14(6):. PubMed ID: 38929687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
    Ren F; Wang DB; Li T
    Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis.
    Kim HS; Kim TH; Chung HH; Song YS
    Br J Cancer; 2014 Apr; 110(7):1878-90. PubMed ID: 24518590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding malignant transformation of endometriosis: imaging features with pathologic correlation.
    Robinson KA; Menias CO; Chen L; Schiappacasse G; Shaaban AM; Caserta MP; Elsayes KM; VanBuren WM; Bolan CW
    Abdom Radiol (NY); 2020 Jun; 45(6):1762-1775. PubMed ID: 30941451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and significance of GLI1 and Shh in the malignant transformation of ovarian endometriosis].
    Zhao F; Yu XP; Zhao H; Song BB; Lyu AW; Zhang SH; Wang LM
    Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):125-132. PubMed ID: 35184473
    [No Abstract]   [Full Text] [Related]  

  • 12. How Does Endometriosis Lead to Ovarian Cancer? The Molecular Mechanism of Endometriosis-Associated Ovarian Cancer Development.
    Yachida N; Yoshihara K; Yamaguchi M; Suda K; Tamura R; Enomoto T
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometriosis-associated Ovarian Cancer is a Subset With a More Favorable Outcome and Distinct Clinical-pathologic Characteristics.
    Bassiouny D; El-Baz MA; Gamil TM; Shams N; Ismiil N; Dubé V; Han G; Cesari M; Lu FI; Slodkowska E; Chiu HF; Naeim M; Li N; Nofech-Mozes S; Khalifa MA
    Int J Gynecol Pathol; 2019 Sep; 38(5):435-442. PubMed ID: 30059454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The High Expression of RRM2 Can Predict the Malignant Transformation of Endometriosis.
    Yang B; Wang T; Li N; Zhang W; Hu Y
    Adv Ther; 2021 Oct; 38(10):5178-5190. PubMed ID: 34424503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of initial symptoms in endometriosis-associated ovarian cancer.
    Ono M; Fukuda M; Yamanoi K; Sunada M; Kitamura S; Taki M; Horie A; Yamaguchi K; Hamanishi J; Mandai M
    Turk J Obstet Gynecol; 2024 Mar; 21(1):28-36. PubMed ID: 38440965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy.
    Murakami K; Kotani Y; Nakai H; Matsumura N
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32599890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometriosis-associated ovarian cancer is not a distinct clinical entity among young patients: A 12-year cohort study.
    Cai Y; Yin J; Jin Y; Li Y; Wu M; Yang J; Huang H; Leng J; Pan L
    Eur J Surg Oncol; 2020 May; 46(5):876-882. PubMed ID: 31837932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometriosis-associated ovarian cancer: a clinicopathologic review.
    Steed H; Chapman W; Laframboise S
    J Obstet Gynaecol Can; 2004 Aug; 26(8):709-15. PubMed ID: 15307975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implication for endometriosis associated with ovarian cancer.
    Torng PL
    Gynecol Minim Invasive Ther; 2017; 6(4):152-156. PubMed ID: 30254904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.
    Mandai M; Yamaguchi K; Matsumura N; Baba T; Konishi I
    Int J Clin Oncol; 2009 Oct; 14(5):383-91. PubMed ID: 19856044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.